GlassScriptPhysician profile
Brittany Smith
NPI 1568949386
$4,762.74
in general payments reported to CMS, 2019-2025
36 companies · $1,329 in 2025
The $1,329 reported for 2025 was more than what 90% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $335 · 2022: $867 · 2023: $1,002 · 2024: $1,230 · 2025: $1,329.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,539 · Travel and Lodging: $21.97.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,538.99 |
| Travel and Lodging | $21.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $944.23 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $570.64 | 2021-2025 | Airsupra, Breztri, Farxiga |
| Abbott Laboratories | $468.50 | 2022-2025 | Freestyle Libre 3, Esprit |
| Novo Nordisk INC | $357.40 | 2021-2025 | Wegovy, Rybelsus, Ozempic |
| Glaxosmithkline, LLC. | $245.77 | 2021-2025 | Trelegy Ellipta, Shingrix |
| Medtronic, INC. | $242.84 | 2025 | Symplicity G3 |
| Pfizer INC. | $220.81 | 2023-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $195.27 | 2021-2025 | Jardiance, Jentadueto Xr |
| Phathom Pharmaceuticals, INC. | $151.66 | 2024-2025 | Voquezna |
| Lucid Diagnostics INC. | $125.16 | 2022 | |
| Dexcom, INC. | $117.39 | 2022-2025 | Dexcom G6 Transmitter |
| Lilly USA, LLC | $117.35 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Exact Sciences Corporation | $98.02 | 2023-2025 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $91.46 | 2021-2024 | |
| Vertex Pharmaceuticals Incorporated | $75.70 | 2024-2025 |
Show all 36 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brittany Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.